Classification of two steroids, prostanozol and methasterone, as Schedule III anabolic steroids under the Controlled Substance Act. Final rule |
| |
Authors: | Drug Enforcement Administration |
| |
Affiliation: | Drug Enforcement Administration (DEA), Department of Justice |
| |
Abstract: | ![]() With the issuance of this Final Rule, the Administrator of the DEA classifies the following two steroids as "anabolic steroids' under the Controlled Substances Act (CSA): prostanozol (17[beta]-hydroxy-5[alpha]-androstano[3,2-c]pyrazole) and methasterone (2[alpha],17[alpha]-dimethyl-5[alpha]-androstan-17[beta]-ol-3-one). These steroids and their salts, esters, and ethers are Schedule III controlled substances subject to the regulatory control provisions of the CSA. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|